Hint mode is switched on Switch off
For swift navigation between sections

ADC Therapeutics

PDF download

Choose all Reset all
Download Cancel
Organization name
ADC Therapeutics SA
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC Therapeutics serves customers in the United States, Switzerland, and the United Kingdom.

Awards

News

30/06/2026 ADC Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
05/06/2026 ADC Therapeutics: ZYNLONTA's Positive Lymphoma Trial Results
03/06/2026 ADC Therapeutics: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
04/05/2026 ADC Therapeutics SA (NYSE:ADCT) Q1 2026 Earnings: Revenue Beat Amidst Clinical Pipeline Progress
18/02/2026 ADC Therapeutics: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001771910
Registration is required to get access.